Found: 43
Select item for more details and to access through your institution.
Dexibuprofen ameliorates peripheral and central risk factors associated with Alzheimer's disease in metabolically stressed APPswe/PS1dE9 mice.
- Published in:
- Cell & Bioscience, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13578-021-00646-w
- By:
- Publication type:
- Article
Effects of a High-Fat Diet on Insulin-Related miRNAs in Plasma and Brain Tissue in APP Swe /PS1dE9 and Wild-Type C57BL/6J Mice.
- Published in:
- Nutrients, 2024, v. 16, n. 7, p. 955, doi. 10.3390/nu16070955
- By:
- Publication type:
- Article
State of the Art on Toxicological Mechanisms of Metal and Metal Oxide Nanoparticles and Strategies to Reduce Toxicological Risks.
- Published in:
- Toxics, 2021, v. 9, n. 8, p. 195, doi. 10.3390/toxics9080195
- By:
- Publication type:
- Article
Licochalcone A: A Potential Multitarget Drug for Alzheimer's Disease Treatment.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 18, p. 14177, doi. 10.3390/ijms241814177
- By:
- Publication type:
- Article
Role of c-Jun N-Terminal Kinases (JNKs) in Epilepsy and Metabolic Cognitive Impairment.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 1, p. 255, doi. 10.3390/ijms21010255
- By:
- Publication type:
- Article
Correction to: Peripheral and Central Effects of Memantine in a Mixed Preclinical Mice Model of Obesity and Familial Alzheimer's Disease.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Epigallocatechin-3-Gallate (EGCG) Improves Cognitive Deficits Aggravated by an Obesogenic Diet Through Modulation of Unfolded Protein Response in APPswe/PS1dE9 Mice.
- Published in:
- Molecular Neurobiology, 2020, v. 57, n. 4, p. 1814, doi. 10.1007/s12035-019-01849-6
- By:
- Publication type:
- Article
JNK Isoforms Are Involved in the Control of Adult Hippocampal Neurogenesis in Mice, Both in Physiological Conditions and in an Experimental Model of Temporal Lobe Epilepsy.
- Published in:
- Molecular Neurobiology, 2019, v. 56, n. 8, p. 5856, doi. 10.1007/s12035-019-1476-7
- By:
- Publication type:
- Article
Peripheral and Central Effects of Memantine in a Mixed Preclinical Mice Model of Obesity and Familial Alzheimer’s Disease.
- Published in:
- Molecular Neurobiology, 2018, v. 55, n. 9, p. 7327, doi. 10.1007/s12035-018-0868-4
- By:
- Publication type:
- Article
Early Preclinical Changes in Hippocampal CREB-Binding Protein Expression in a Mouse Model of Familial Alzheimer’s Disease.
- Published in:
- Molecular Neurobiology, 2018, v. 55, n. 6, p. 4885, doi. 10.1007/s12035-017-0690-4
- By:
- Publication type:
- Article
Evaluation of the Role of JNK1 in the Hippocampus in an Experimental Model of Familial Alzheimer's Disease.
- Published in:
- Molecular Neurobiology, 2016, v. 53, n. 9, p. 6183, doi. 10.1007/s12035-015-9522-6
- By:
- Publication type:
- Article
Mice Lacking Functional Fas Death Receptors Are Protected from Kainic Acid-Induced Apoptosis in the Hippocampus.
- Published in:
- Molecular Neurobiology, 2015, v. 52, n. 1, p. 120, doi. 10.1007/s12035-014-8836-0
- By:
- Publication type:
- Article
Memantine‐Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma.
- Published in:
- Small, 2018, v. 14, n. 2, p. 1, doi. 10.1002/smll.201701808
- By:
- Publication type:
- Article
Surface Functionalization of PLGA Nanoparticles to Increase Transport across the BBB for Alzheimer's Disease.
- Published in:
- Applied Sciences (2076-3417), 2021, v. 11, n. 9, p. 4305, doi. 10.3390/app11094305
- By:
- Publication type:
- Article
Exploring small non-coding RNAs as blood-based biomarkers to predict Alzheimer's disease.
- Published in:
- Cell & Bioscience, 2024, v. 14, n. 1, p. 1, doi. 10.1186/s13578-023-01190-5
- By:
- Publication type:
- Article
A novel rhein-huprine hybrid ameliorates disease-modifying properties in preclinical mice model of Alzheimer's disease exacerbated with high fat diet.
- Published in:
- Cell & Bioscience, 2023, v. 13, n. 1, p. 1, doi. 10.1186/s13578-023-01000-y
- By:
- Publication type:
- Article
Current Research Therapeutic Strategies for Alzheimer’s Disease Treatment.
- Published in:
- Neural Plasticity, 2016, p. 1, doi. 10.1155/2016/8501693
- By:
- Publication type:
- Article
Plasma extracellular vesicles reveal early molecular differences in amyloid positive patients with early-onset mild cognitive impairment.
- Published in:
- Journal of Nanobiotechnology, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12951-023-01793-7
- By:
- Publication type:
- Article
JNK1 and JNK3: divergent functions in hippocampal metabolic-cognitive function.
- Published in:
- Molecular Medicine, 2022, v. 28, n. 1, p. 1, doi. 10.1186/s10020-022-00471-y
- By:
- Publication type:
- Article
Isoform‐selective as opposed to complete depletion of fibroblast growth factor 2 (FGF‐2) has no major impact on survival and gene expression in SOD1<sup>G93A</sup> amyotrophic lateral sclerosis mice.
- Published in:
- European Journal of Neuroscience, 2019, v. 50, n. 6, p. 3028, doi. 10.1111/ejn.14405
- By:
- Publication type:
- Article
Extracellular vesicles, the emerging mirrors of brain physiopathology.
- Published in:
- International Journal of Biological Sciences, 2023, v. 19, n. 3, p. 721, doi. 10.7150/ijbs.79063
- By:
- Publication type:
- Article
Peroxisomal Proliferator-Activated Receptor ß/d Deficiency Induces Cognitive Alterations.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.902047
- By:
- Publication type:
- Article
Role of brain c‐Jun N‐terminal kinase 2 in the control of the insulin receptor and its relationship with cognitive performance in a high‐fat diet pre‐clinical model.
- Published in:
- Journal of Neurochemistry, 2019, v. 149, n. 2, p. 255, doi. 10.1111/jnc.14682
- By:
- Publication type:
- Article
Benzodiazepines and Related Drugs as a Risk Factor in Alzheimer's Disease Dementia.
- Published in:
- Frontiers in Aging Neuroscience, 2020, v. 11, p. 1, doi. 10.3389/fnagi.2019.00344
- By:
- Publication type:
- Article
Characterizing the multiple roles of FGF‐2 in SOD1<sup>G93A</sup> ALS mice in vivo and in vitro.
- Published in:
- Journal of Cellular Physiology, 2019, v. 234, n. 5, p. 7395, doi. 10.1002/jcp.27498
- By:
- Publication type:
- Article
c-Jun N-terminal Kinase 1 ablation protects against metabolic-induced hippocampal cognitive impairments.
- Published in:
- Journal of Molecular Medicine, 2019, v. 97, n. 12, p. 1723, doi. 10.1007/s00109-019-01856-z
- By:
- Publication type:
- Article
Biodegradable nanoparticles for the treatment of epilepsy: From current advances to future challenges.
- Published in:
- Epilepsia Open, 2022, v. 7, p. S121, doi. 10.1002/epi4.12567
- By:
- Publication type:
- Article
State-of-the-art polymeric nanoparticles as promising therapeutic tools against human bacterial infections.
- Published in:
- Journal of Nanobiotechnology, 2020, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12951-020-00714-2
- By:
- Publication type:
- Article
Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization.
- Published in:
- Journal of Nanobiotechnology, 2018, v. 16, p. 1, doi. 10.1186/s12951-018-0356-z
- By:
- Publication type:
- Article
Dexibuprofen Biodegradable Nanoparticles: One Step Closer towards a Better Ocular Interaction Study.
- Published in:
- Nanomaterials (2079-4991), 2020, v. 10, n. 4, p. 720, doi. 10.3390/nano10040720
- By:
- Publication type:
- Article
Metal-Based Nanoparticles as Antimicrobial Agents: An Overview.
- Published in:
- Nanomaterials (2079-4991), 2020, v. 10, n. 2, p. 292, doi. 10.3390/nano10020292
- By:
- Publication type:
- Article
Current Applications of Nanoemulsions in Cancer Therapeutics.
- Published in:
- Nanomaterials (2079-4991), 2019, v. 9, n. 6, p. 821, doi. 10.3390/nano9060821
- By:
- Publication type:
- Article
Exosomes-Based Nanomedicine for Neurodegenerative Diseases: Current Insights and Future Challenges.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 1, p. 298, doi. 10.3390/pharmaceutics15010298
- By:
- Publication type:
- Article
Development of Peptide Targeted PLGA-PEGylated Nanoparticles Loading Licochalcone-A for Ocular Inflammation.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 2, p. 285, doi. 10.3390/pharmaceutics14020285
- By:
- Publication type:
- Article
Lipid Nanoparticles for the Posterior Eye Segment.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 1, p. 90, doi. 10.3390/pharmaceutics14010090
- By:
- Publication type:
- Article
Advanced Formulation Approaches for Ocular Drug Delivery: State-Of-The-Art and Recent Patents.
- Published in:
- Pharmaceutics, 2019, v. 11, n. 9, p. 460, doi. 10.3390/pharmaceutics11090460
- By:
- Publication type:
- Article
Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 10, p. 1057, doi. 10.3390/ph14101057
- By:
- Publication type:
- Article
Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer's Disease Treatment.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 9, p. 890, doi. 10.3390/ph14090890
- By:
- Publication type:
- Article
Cannabidiol (CBD) Alters the Functionality of Neutrophils (PMN). Implications in the Refractory Epilepsy Treatment.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 3, p. 220, doi. 10.3390/ph14030220
- By:
- Publication type:
- Article
The Implication of the Brain Insulin Receptor in Late Onset Alzheimer's Disease Dementia.
- Published in:
- Pharmaceuticals (14248247), 2018, v. 11, n. 1, p. 11, doi. 10.3390/ph11010011
- By:
- Publication type:
- Article
Angiotensin Receptor Blockers as an Alternative Strategy for Addressing Neurodegeneration in a LPS Mice Model.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.072781
- By:
- Publication type:
- Article
Proteomic analysis reveal early differences in plasma exosomes of Aβ(+) vs Aβ(‐) patients with early‐onset mild cognitive impairment: from BIOFACE to BIOPEXAL study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.075501
- By:
- Publication type:
- Article
Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer's disease: from current to future challenges.
- Published in:
- Journal of Nanobiotechnology, 2021, v. 19, n. 1, p. 1, doi. 10.1186/s12951-021-00864-x
- By:
- Publication type:
- Article